Prediction of acute cellular renal allograft rejection by urinary metabolomics using MALDI-FTMS

Journal of Proteome Research

Volumn 7, Issue 8, 2008, Pages 3597-3601

  Wang, Ji Na ^a   Zhou, Ying ^b   Zhu, Tong Yu ^a   Wang, Xiangdong ^a   Guo, Yin Long ^b  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

Author keywords

Acute cellular rejection; Kidney transplantation; MALDI FTMS; Metabolomics; Urine

Indexed keywords

ACUTE GRAFT REJECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FOURIER TRANSFORM MASS SPECTROMETRY; HUMAN; HUMAN TISSUE; KIDNEY GRAFT REJECTION; METABOLOMICS; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; URINALYSIS; ALLOTRANSPLANTATION; CAPILLARY ELECTROPHORESIS; FOURIER ANALYSIS; GRAFT REJECTION; KIDNEY TRANSPLANTATION; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PREDICTION AND FORECASTING; URINE;

BIOLOGICAL MARKER; PROTEOME;

BIOLOGICAL MARKERS; ELECTROPHORESIS, CAPILLARY; FOURIER ANALYSIS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 53049094382     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800092f     Document Type: Article

References (26)

1. Agodoa, L.; Eknoyan, G.; Ingelfinger, J, et al. Assessment of structure and function in progressive renal disease. Kidney Int. Suppl. 1997, 63, S144-S150.
2. Hariharan, S.; Johnson, C. P.; Bresnahan, B. A. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N. Engl. J. Med. 2000, 342, 605-612.
3. McLaren, A. J.; Fuggle, S. V.; Welsh, K. I.; et al. Chronic allograft failure in human renal transplantation. Ann. Surg. 2000, 232, 98- 103.
4. Li, B.; Hartono, C; Ding, R.; et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N. Engl. J. Med. 2001, 344, 947-954.
5. Roberti, I.; Reisman, L. Serial evaluation of cell surface markers for immune activation after acute renal allograft rejection by urine flow cytometry: correlation with clinical outcome. Transplantation 2001, 71, 1317-1320.
6. Woodle, E. S.; Cronin, D.; Newell, K. A. Tacrolimus therapy for refractoryacute renal allograft rejection. Transplantation 1996, 62, 906.
7. Beckingham, I. J.; Nicholson, M. L.; Bell, P. R. Analysis of factors associated complications following renal transplant needle core biopsy. Br. J. Urol. 1994, 73, 13-15.
8. Rush, D. N.; Henry, S. F.; Jeffery, J. R. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994, 57, 208-211.
9. Gaber, L. W.; Moore, L. W.; Gaber, A. O. Correlation of histology to clinical rejection reversal: a thymoglobulin multicenter trial report. Kidney Int. 1999, 55, 2415-2422.
10. Veronese, F. V.; Manfro, R. C; Roman, F. R. Reproducibility of the Banff classification in subclinical kidney transplant rejection. Clin. Transplant 2005, 19, 518-521.
11. Roberti, I.; Reisman, L. Serial evaluation of cell surface markers for immune activation after acute renal allograft rejection by urine flow cytometry-correlation with clinical outcome. Transplantation 2001, 71, 1317-1320.
12. Curtis, J. I.; lulian, B. A.; Sanders, C. E. Dilemmas in renal transplantation: when the clinical course and histological findings differ. Am. J. Kidney Dis. 1996, 27, 435.
13. Sorof, J. M.; Vartarian, R. K.; Olson, J. L. Histological concordance of paired renal allograft biopsy cores. Transplantation 1995, 60, 1215.
14. Mckee, J. A.; Kumar, S.; Ecelbarger, C. A. Detection of Na(+) transporter proteins in urine. J. Am. Soc. Nephrol. 2000, 11, 2128- 2132.
15. Ohkaru, Y.; Asayama, K.; Ishii, H. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J. Immunol. Methods 1995, 178, 99-111.
16. Thongboonkerd, V.; Klein, J. B.; Pierce, W. M. Sodium loading changes urinary protein excretion: Aproteomic analysis. Am. J. Physiol: Renal Physiol. 2003, 284, F1155-F1163.
17. Jellum, E. Chromatography for diagnosis of metabolic diseases. J. Chromatogr., A 1988, 452, 435-441.
18. Fiehn, O. Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol. 2002, 48, 155-171.
19. Schaub, S.; Wilkins, J.; Weiler, T. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-fliight mass spectrometry. Kidney Int. 2004, 65, 323-332.
20. Clarke, W.; Silverman, B. C; Zhang, Z. Characterization of renal allograft rejection by urinary proteomic analysis. Ann. Surg. 2003, 237, 660-665.
21. Schaub, S.; Rush, D.; Wilkins, J. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 2004, 15, 219-227.
22. Schaub, S.; Wilkins, J. A.; Antonovici, M. Proteomic-based identification of cleaved urinary β32-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant. 2005, 5, 729-738.
23. O'Riordan, E.; Orlova, T. N.; Mei, J. J. Bioinformatic analysis of the urine proteome of acute allograft rejection. J. Am. Soc. Nephrol. 2004, 15, 3240-3248.
24. Reichelt, O.; Muller, J.; von Eggeling, F. Prediction of renal allograft rejection by urinary protein analysis using ProteinChip Arrays (surface-enhanced laser desorption/ionization time-of-flight mass spectrometry). Urology 2006, 67(3):), 472-475.
25. Wittkea, S.; Haubitzb, M.; Waldena, M. Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am. J. Transplant. 2005, 5, 2479- 2488.
26. Wishart, D. S. Metabolomics: the principles and applications to transplantation. Am. J. Transplant. 2005, 5, 2814-2820.